Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Will the Prostate Cancer Prevention Trial affect population mortality rates?

Nature Clinical Practice Urology volume 2, pages 526–527 (2005)Cite this article

boxed-textUnger JM et al. (2005) Estimated impact of the Prostate Cancer Prevention Trial on population mortality. Cancer 103: 1375–1380

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Thompson IM et al. (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349: 215–224

    Article  CAS  Google Scholar 

  2. Unger JM et al. (2003) Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture. J Clin Oncol 21 (Suppl 23): S246–S252

    Article  Google Scholar 

  3. Civantos F et al. (1996) Histopathological effects of androgen deprivation in prostatic cancer. Semin Urol Oncol 14 (Suppl 2): 22–31

    CAS  PubMed  Google Scholar 

  4. Yang XJ et al. (1999) Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? Urology 53: 696–700

    Article  CAS  Google Scholar 

  5. Iversen P et al. (2004) Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6. J Urol 172: 1871–1876

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor and Chair of the Department of Urology, Jikei University School of Medicine, Tokyo, Japan

    Shin Egawa

Authors
  1. Shin Egawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shin Egawa.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Egawa, S. Will the Prostate Cancer Prevention Trial affect population mortality rates?. Nat Rev Urol 2, 526–527 (2005). https://doi.org/10.1038/ncpuro0327

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0327

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing